Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Reexamination Certificate
2007-04-17
2007-04-17
McGarry, Sean (Department: 1635)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
C435S006120, C435S375000, C435S377000, C536S024100, C536S024500
Reexamination Certificate
active
10766185
ABSTRACT:
New antisense oligonucleotide compounds, RX-0047 and RX-0149, inhibit expression of HIF-1 and also induce cytotoxicity in several cancer cell lines.
REFERENCES:
patent: 6222018 (2001-04-01), Semenza
patent: 2004/0096848 (2004-05-01), Thrue et al.
patent: 2004/0220393 (2004-11-01), Ward et al.
Hypoxia-inducible factor: Achilles′ heel of antiangiogenic cancer therapy (Review), Blagosklonny, M.V., International Journal of Oncology 19: 257-262 (2001).
Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate-Phenol-Chloroform Extraction, Chomczynski, P. and Sacchi, N., Analytical Biochemistry 162: 156-159 (1987).
Activation of Vascular Endothelial Growth Factor Gene Transcription by Hypoxia-Inducible Factor 1, Forsythe, J.A., et al., Molecular and Cellular Biology, vol. 16, No. 9: 4604-4613 (1996).
The von Hippel-Lindau tumor suppressor protein, Ivan, M. and Kaelin, W.G., Jr., Current Opinion in Genetics & Development, 11: 27-34 (2001).
Targeting of HIF-a to the von Hippel-Lindau Ubiquitylation Complex by O2-regulated prolyl Hydorxylation, Jaakola, P., et al., Science 292: 468-472 (2001).
Regulation and Destabilization of HIF-1-a by ARD1-Mediated Acetylation, Jeong, J.W., et al., Cell, 111: 709-720 (2002).
Asparagine Hydroxylation of the HIF Transactivation Domain: A Hypoxic Switch, Lando, D., et al., Science 295: 858-861 (2002).
38. Ein neuer Zugang zu 2′-O-alkylribonucleosiden und Eigenschaften deren Oligonucleotide, Martin, v. P. Helvetica Chimica Acta 78: 486-504 (1995).
aHIF: the Missing Link between HIF-1 and VHL? Neckers, M. N., J. Nat'l. Cancer Inst., vol. 91, No. 2: 106-7 (1999).
HIF-1 and human disease: one highly involved factor, Semenza, G. L., Genes & Development 14: 1983-1991 (2000).
Regulation of Hypoxia-induced angiogenesis: a chaperone excorts VEGF to the dance, Semenza.G. I.., J. Clin. Investigation vol. 108, No. 1: 39-40 (2001).
Overexpression of Hypoxia-Inducible Factor 1a in Common Human Cancers and Their Metastases, Zhong, H. et al., Cancer Research 59: 5830-5835 (1999).
Ahn Chang-Ho
Jiang Xiaoming
Lee Young Bok
Mao Lingjun
Yoon Heejeong
Looper Valerie E.
McGarry Sean
Rexahn Corporation
LandOfFree
Antisense oligonucleotides that inhibit expression of HIF-1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antisense oligonucleotides that inhibit expression of HIF-1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antisense oligonucleotides that inhibit expression of HIF-1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3773262